Waters (WAT) SEC Filings: History & Chart

Waters Corporation(WAT)

Medical - Diagnostics & Research · Milford, MA

$404.81+0.00 (+0.00%)

Delayed quote: Sep 9, 2026, 4:00 PM EDT

About Waters Corporation

Waters Corporation is a global leader in specialized measurement, delivering analytical solutions across Asia, the Americas, and Europe. The company operates through two main divisions: Waters and TA. Under its Waters segment, it engineers, manufactures, sells, and provides support for high and ultra-performance liquid chromatography and mass spectrometry (MS) systems. This includes essential consumables like chromatography columns and comprehensive post-warranty service plans. The TA segment focuses on designing, producing, selling, and servicing instruments for thermal analysis, rheometry, and calorimetry. Additionally, Waters develops and supplies sophisticated software that integrates with both its own instruments and those from other manufacturers. The company's advanced MS technology plays a crucial role in various applications, such as drug discovery and development (including clinical trial assessments), analyzing proteins involved in disease processes, ensuring nutritional safety, and conducting environmental testing. Its thermal analysis, rheometry, and calorimetry instruments are vital for assessing the suitability and stability of a wide range of materials, including fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids. These instruments support diverse sectors like industrial manufacturing, consumer goods, healthcare products, and life science research. Waters' extensive client base spans the life sciences, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental sectors, where its products are instrumental in research and development, quality assurance, and general laboratory operations. Established in 1958, Waters Corporation is headquartered in Milford, Massachusetts.

Milford, MA

7,900 employees

www.waters.com

Healthcare / Medical - Diagnostics & Research

Sector: Healthcare
Industry: Medical - Diagnostics & Research
CEO: Udit Batra

View full financials

Form	Filing Date	Accepted	Document
3	Aug 31, 2026	Aug 31, 2026	View filing
8-K	Aug 21, 2026	Aug 21, 2026	View filing
10-Q	Aug 11, 2026	Aug 11, 2026	View filing
4	Aug 7, 2026	Aug 7, 2026	View filing
8-K	Aug 4, 2026	Aug 4, 2026	View filing
4	Jul 2, 2026	Jul 2, 2026	View filing
4	Jul 2, 2026	Jul 2, 2026	View filing
4	Jun 25, 2026	Jun 25, 2026	View filing
11-K	Jun 25, 2026	Jun 25, 2026	View filing
SD	May 29, 2026	May 29, 2026	View filing
8-K	May 22, 2026	May 22, 2026	View filing
SC 13G/A	May 15, 2026	May 15, 2026	View filing
4	May 14, 2026	May 14, 2026	View filing
10-Q	May 12, 2026	May 12, 2026	View filing
8-K	May 5, 2026	May 5, 2026	View filing
SC 13G	Apr 30, 2026	Apr 30, 2026	View filing
SC 13G/A	Apr 24, 2026	Apr 24, 2026	View filing
ARS	Apr 9, 2026	Apr 9, 2026	View filing
DEFA14A	Apr 9, 2026	Apr 9, 2026	View filing
DEF 14A	Apr 9, 2026	Apr 9, 2026	View filing
4	Apr 7, 2026	Apr 7, 2026	View filing
4	Apr 2, 2026	Apr 2, 2026	View filing
4	Apr 2, 2026	Apr 2, 2026	View filing
SC 13G/A	Mar 27, 2026	Mar 27, 2026	View filing
8-K	Mar 23, 2026	Mar 23, 2026	View filing
424B2	Mar 19, 2026	Mar 19, 2026	View filing
4	Mar 18, 2026	Mar 18, 2026	View filing
FWP	Mar 17, 2026	Mar 17, 2026	View filing
424B2	Mar 16, 2026	Mar 16, 2026	View filing
S-3ASR	Mar 16, 2026	Mar 16, 2026	View filing

SEC Filings

Recent Filings